Aussprung L. Fraud and abuse: federal civil medical care litigation and settlement. J Leg Med. 1998;19:1–62.

Bennett T, Gerber RS, Mueller DG Jr. Making sense of antitrust policy: its application to physician directed networks. Mo Med. 1997;94:180–184.

Bloche MG. Cutting waste and keeping faith. Ann Intern Med. 1998;128:688–689.

Boyd W III. Combating fraud and abuse: anti-kickback statute. Iowa Med. 1997;87:23–24.

Boyer MM. Fraud and abuse gaining attention amid national E&M guideline controversy. Pa Med. 1998;101:12.

Cook DA. Fraud, abuse, and beyond: costly pitfalls for physicians who serve Medicare and Medicaid patients. J Med Assoc Ga. 1997;86:321–324.

Cook DA. New antitrust rules ease restrictions on physician networks. J Med Assoc Ga. 1996;85:257–259.

DeWitt AL. The citizen attorney general and Medicare fraud. Mo Med. 1996;93:688–689.

Dranove D, White WD. Emerging issues in the antitrust definition of healthcare markets. Health Econ. 1998;7:167–170.

Farrell MG. ERISA preemption and regulation of managed medical care: the case for managed federalism. Am J Law Med. 1997;23:251–289.

Feldman R, Given RS. HMO mergers and Medicare: the antitrust issues. Health Econ. 1998;7:171–174.

Fifer WR. Compliance...or else! Minn Med. 1998;81:46–48.

Forgione DA. Corporate compliance plans in medical care organizations: a top- down perspective. J Health Care Finance. 1998;24:87–92.

Frech HE III, Danger KL. Exclusive contracts between hospitals and physicians: the antitrust issues. Health Econ. 1998;7:175–178.

Glaser D. 500 FBI agents. Iowa Med. 1996;86:110–112.

Glaser D. What to do if an investigator is at your office door. Iowa Med. 1996;86:113–114.

Glaser DM. Medical care audits and investigations: act now to avoid trouble later. Minn Med. 1996;79:43–46.

Greaney TL. Night landings on an aircraft carrier: hospital mergers and antitrust law. Am J Law Med. 1997;23:191– 220.

Hebert DE, Ogaitis JM. Revised antitrust policy statements on healthcare. AANA J. 1996;64:512–514.

Hirshfeld EB. Provider sponsored organizations and provider service networks—rationale and regulation. Am J Law Med. 1996;22:263–300.

Hoffman DR. The federal effort to eliminate fraud and ensure quality care. Adv Wound Care. 1997;10:36–38.

Iglehart JK. Pursuing medical care fraud and abuse. Health Aff (Millwood). 1998;17:6.

Jost TS, Davies S. The fraud and abuse statute: rationalizing or rationalization? Health Aff (Millwood). 1996;15:129–131.

Kleinke JD. Deconstructing the Columbia/HCA investigation. Health Aff (Millwood). 1998;17:7–26.

Kurlander SS, Scherb E. Liability under the False Claims Act for inadequate care of nursing facility residents. Adv Wound Care. 1997;10:47–49.

Kuttner R. Physician-operated networks and the new antitrust guidelines. N Engl J Med. 1997;336:386–391.

Lawton SE, Leibenluft RF, Loeb LE. Antitrust implications of physicians’ responses to managed care. Clin Infect Dis. 1995;20:1354–1360.

Liggett N. New law adds significant penalties for the waiver of copayments. Tenn Med. 1997;90:354–355.

Luce GM, Graham JJ. Responding to a medical care fraud investigation: a practice guide. Va Med Q. 1996;123:9–13.

Lundquist JW, Glaser DM. Fraud investigations: the heat is on. Minn Med. 1998;81:49–51.

Mason C. Who carries the risk? Networks, antitrust, and carve- outs. Acad Radiol. 1996;3:S150–S153.

McCampbell RG. Fraud and abuse provisions in the Health Insurance Portability and Accountability Act: a guide to the new act for physicians. J Okla State Med Assoc. 1997;90:139–141.

McMenamin JP, Scoggins GA. Developing a compliance program to identify and prevent inaccurate or improper Medicare billing practices. Va Med Q. 1998;125:12–14.

Meyer A. The Health Insurance Portability and Accountability Act. Tenn Med. 1997;90:86–89.

Miale PA. Wake-up call: can you protect yourself and your nuclear medicine practice from fraud and abuse? J Nucl Med. 1998;39:21N–22N.

Minarik PA. Opposition to antitrust legislation: support for Medicaid and Medicare reimbursement. Clin Nurse Spec. 1997;11:139–140.

Murphy LS. How much should physicians worry about antitrust? Del Med J. 1997;69:305–309.

Nordenberg T. Selling drug samples lands doctor in prison. FDA Consum. 1998;32:39.

Ortolon K. Medicare rerun: congress tinkers with but does not fix Medicare solvency. Tex Med. 1997;93:28–32.

Parmley WW. Public enemy number 2: academic medicine under the Federal spotlight. J Am Coll Cardiol. 1997;29:11– 17.

Phillips JR. Qui tam litigation: a new forum for prosecuting false claims against the government. J Leg Med. 1993;14:267–277.

Polston MD. Reporting fraud. Am J Nurs. 1998;98:78.

Pristave RJ, Riley JB Jr. OIG on the warpath, II: when the OIG knocks on your door. Nephrol News Issues. 1996;10:45–46.

Russell LS. Fraud, abuse, and IDSs. J Law Med Ethics. 1996;24:162–166.

Sage WM. Judge Posner’s RFP: antitrust law and managed care. Health Aff (Millwood). 1997;16:44–61.

Shepherd SR. The rewards of exposing fraud against the government. J Pract Nurs. 1997;47:4–7.

Smith JJ, Gay SB. Reducing the number of radiology residents: antitrust and action by the Accreditation Council for Graduate Medical Education. Acad Radiol. 1996;3:766–769.

Spear SL. On the importance of being honest. Plast Reconstr Surg. 1998;102:899.

Stahl DA. Consolidated billing and compliance program— Part 1. Nurs Manage. 1998;29:16–18.

Stahl DA. Consolidated billing and compliance program— Part 2. Nurs Manage. 1998;29:12–15.

Ward RD. Medicare fraud and abuse. Mich Med. 1998;98:24– 31.